Chinese (SSE) Healthcare Sector Analysis
UpdatedMar 18, 2023
DataAggregated Company Financials
Companies458
- 7D-2.1%
- 3M-2.7%
- 1Y-8.9%
- YTD0.07%
Over the last 7 days, the Healthcare industry has remained flat, although notably Shenzhen Mindray Bio-Medical Electronics gained 3.5%. Furthermore, the industry has been flat for the past year as well. As for the next few years, earnings are expected to grow by 25% per annum.
Sector Valuation and Performance
Has the Chinese Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 18 Mar 2023 | CN¥7.0t | CN¥2.2t | CN¥231.0b | 37.5x | 30.2x | 3.2x |
| Mon, 13 Feb 2023 | CN¥7.4t | CN¥2.2t | CN¥233.1b | 37.9x | 31.6x | 3.3x |
| Wed, 11 Jan 2023 | CN¥7.1t | CN¥2.2t | CN¥232.2b | 36.8x | 30.7x | 3.2x |
| Fri, 09 Dec 2022 | CN¥7.1t | CN¥2.2t | CN¥231.9b | 38x | 30.5x | 3.2x |
| Sun, 06 Nov 2022 | CN¥6.9t | CN¥2.2t | CN¥231.0b | 37.1x | 30.1x | 3.2x |
| Tue, 04 Oct 2022 | CN¥6.1t | CN¥2.1t | CN¥223.7b | 31.1x | 27.5x | 2.9x |
| Thu, 01 Sep 2022 | CN¥6.5t | CN¥2.1t | CN¥220.8b | 33.4x | 29.4x | 3.1x |
| Sat, 30 Jul 2022 | CN¥6.5t | CN¥2.1t | CN¥226.9b | 32.5x | 28.7x | 3.2x |
| Mon, 27 Jun 2022 | CN¥6.8t | CN¥2.0t | CN¥226.0b | 34.6x | 30x | 3.3x |
| Wed, 25 May 2022 | CN¥6.1t | CN¥2.0t | CN¥224.1b | 31.5x | 27.2x | 3x |
| Fri, 22 Apr 2022 | CN¥6.2t | CN¥2.0t | CN¥213.2b | 31.8x | 29.3x | 3.2x |
| Sun, 20 Mar 2022 | CN¥7.0t | CN¥2.0t | CN¥213.8b | 36.4x | 32.6x | 3.6x |
| Tue, 15 Feb 2022 | CN¥6.6t | CN¥1.9t | CN¥206.1b | 34.3x | 32x | 3.4x |
| Thu, 13 Jan 2022 | CN¥7.8t | CN¥1.9t | CN¥205.5b | 43x | 38.1x | 4.1x |
| Sat, 11 Dec 2021 | CN¥7.8t | CN¥1.9t | CN¥204.4b | 38.2x | 37.9x | 4x |
| Mon, 08 Nov 2021 | CN¥7.4t | CN¥1.9t | CN¥202.4b | 35.1x | 36.3x | 3.8x |
| Wed, 06 Oct 2021 | CN¥7.7t | CN¥1.9t | CN¥203.9b | 36x | 37.9x | 4.1x |
| Fri, 03 Sep 2021 | CN¥7.3t | CN¥1.9t | CN¥200.6b | 36.5x | 36.3x | 3.9x |
| Sun, 01 Aug 2021 | CN¥8.0t | CN¥1.9t | CN¥198.5b | 38.7x | 40.5x | 4.3x |
| Wed, 05 May 2021 | CN¥8.4t | CN¥1.8t | CN¥189.6b | 37.5x | 44.4x | 4.7x |
| Sat, 06 Feb 2021 | CN¥7.8t | CN¥1.7t | CN¥157.0b | 37x | 49.7x | 4.7x |
| Tue, 10 Nov 2020 | CN¥7.5t | CN¥1.6t | CN¥123.7b | 46.7x | 60.5x | 4.7x |
| Mon, 03 Aug 2020 | CN¥7.9t | CN¥1.5t | CN¥101.7b | 54.6x | 77.8x | 5.2x |
| Thu, 07 May 2020 | CN¥5.2t | CN¥1.5t | CN¥82.6b | 44.2x | 62.9x | 3.4x |
Price to Earnings Ratio
59.1x
Current Industry PE
- Investors are pessimistic on the Chinese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 30.9x which is lower than its 3-year average PE of 43.3x.
- The 3-year average PS ratio of 3.9x is higher than the industry's current PS ratio of 3.2x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 41% per year over the last three years.
- Revenues for these companies have grown 14% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare sector?
| CN Market | -0.65% | |
| Healthcare | -2.10% | |
| Healthtech | 7.00% | |
| Healthcare Services | -0.45% | |
| Pharma | -0.71% | |
| Biotech | -2.59% | |
| Medical Equipment | -3.79% | |
| Life Sciences | -6.86% | |
Industry PE
- Investors are most optimistic about the Healthtech industry, which is trading close to its 3-year average PE ratio of 68.0x.
- Analysts are expecting annual earnings growth of 40.7%, which is higher than its past year's earnings growth of 2.4% per year.
- Investors are most pessimistic about the Medical Equipment industry, which is trading below its 3-year average of 32.6x.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 41% over the next 5 years.
- This is better than its past earnings growth rate of 2.4% per year.
- In contrast, the Life Sciences industry is expected to see its earnings grow by 17% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 688506 Sichuan Biokin PharmaceuticalLtd | CN¥78.10 | 23.1% +CN¥5.9b | n/a | PS44.5x | |
| 601607 Shanghai Pharmaceuticals Holding | CN¥21.30 | 6.8% +CN¥5.0b | -5.2% | PE14.5x | |
| 999 China Resources Sanjiu Medical & Pharmaceutical | CN¥57.62 | 8.5% +CN¥4.4b | 58.9% | PE23.3x | |
| 28 China National Accord Medicines | CN¥49.05 | 18.4% +CN¥3.3b | 48.8% | PE16x | |
| 600161 Beijing Tiantan Biological Products | CN¥24.87 | 7.9% +CN¥3.0b | 14.0% | PE46.7x |